Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication Date
9-15-2022
Volume
28
Issue
18
First Page
4092
Last Page
4104
Document Type
Open Access Publication
DOI
10.1158/1078-0432.CCR-21-4504
Rights and Permissions
Nathenson MJ, Hu J, Ratan R, Somaiah N, Hsu R, DeMaria PJ, Catoe HW, Pang A, Subhawong TK, Amini B, Sweet K, Feister K, Malik K, Jagannathan J, Braschi-Amirfarzan M, Sheren J, Caldas Y, Moreno Tellez C, Rosenberg AE, Lazar AJ, Maki RG, Benedetto P, Cohen J, Trent JC, Ravi V, Patel S, Wilky BA. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study. Clin Cancer Res. 2022 Sep 15;28(18):4092-4104. doi: 10.1158/1078-0432.CCR-21-4504 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Recommended Citation
Nathenson, Michael J; Feister, Katharina; and Et al, "Systemic chemotherapies retain antitumor activity in desmoid tumors independent of specific mutations in CTNNB1 or APC: A multi-institutional retrospective study." Clinical cancer research : an official journal of the American Association for Cancer Research. 28, 18. 4092 - 4104. (2022).
https://digitalcommons.wustl.edu/oa_4/413
